KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Return on Capital Employed (2018 - 2025)

Historic Return on Capital Employed for Bionano Genomics (BNGO) over the last 8 years, with Q3 2025 value amounting to 0.67%.

  • Bionano Genomics' Return on Capital Employed rose 8800.0% to 0.67% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.67%, marking a year-over-year increase of 8800.0%. This contributed to the annual value of 0.96% for FY2024, which is 3800.0% up from last year.
  • According to the latest figures from Q3 2025, Bionano Genomics' Return on Capital Employed is 0.67%, which was up 8800.0% from 1.36% recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' Return on Capital Employed registered a high of 0.14% during Q2 2021, and its lowest value of 2.33% during Q4 2024.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.59% (2023), whereas its average is 0.93%.
  • As far as peak fluctuations go, Bionano Genomics' Return on Capital Employed skyrocketed by 198900bps in 2021, and later crashed by -17200bps in 2023.
  • Over the past 5 years, Bionano Genomics' Return on Capital Employed (Quarter) stood at 0.22% in 2021, then tumbled by -112bps to 0.47% in 2022, then plummeted by -366bps to 2.19% in 2023, then decreased by -6bps to 2.33% in 2024, then surged by 71bps to 0.67% in 2025.
  • Its Return on Capital Employed was 0.67% in Q3 2025, compared to 1.36% in Q2 2025 and 1.59% in Q1 2025.